| Necroptosis microenvironment directs lineage commitment in liver cancer M Seehawer, F Heinzmann, L D’artista, J Harbig, PF Roux, L Hoenicke, ... Nature 562 (7725), 69-75, 2018 | 360 | 2018 |
| The immunological and metabolic landscape in primary and metastatic liver cancer X Li, P Ramadori, D Pfister, M Seehawer, L Zender, M Heikenwalder Nature Reviews Cancer 21 (9), 541-557, 2021 | 310 | 2021 |
| PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells A Georgilis, S Klotz, CJ Hanley, N Herranz, B Weirich, B Morancho, ... Cancer cell 34 (1), 85-102. e9, 2018 | 185 | 2018 |
| Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS D Yuan, S Huang, E Berger, L Liu, N Gross, F Heinzmann, M Ringelhan, ... Cancer cell 31 (6), 771-789. e6, 2017 | 181 | 2017 |
| microRNA 193a-5p regulates levels of nucleolar-and spindle-associated protein 1 to suppress hepatocarcinogenesis S Roy, GJ Hooiveld, M Seehawer, S Caruso, F Heinzmann, AT Schneider, ... Gastroenterology 155 (6), 1951-1966. e26, 2018 | 83 | 2018 |
| Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer C Hinterleitner, J Strähle, E Malenke, M Hinterleitner, M Henning, ... Nature communications 12 (1), 7005, 2021 | 81 | 2021 |
| Untangling the web of intratumour heterogeneity Z Li, M Seehawer, K Polyak Nature cell biology 24 (8), 1192-1201, 2022 | 46 | 2022 |
| JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States LE Stevens, G Peluffo, X Qiu, D Temko, A Fassl, Z Li, A Trinh, ... Cancer research 83 (2), 264-284, 2023 | 36 | 2023 |
| FAT1 expression and mutations in adult acute lymphoblastic leukemia M Neumann, M Seehawer, C Schlee, S Vosberg, S Heesch, ... Blood cancer journal 4 (6), e224-e224, 2014 | 25 | 2014 |
| The worst from both worlds: cHCC-ICC M Seehawer, L D’Artista, L Zender Cancer Cell 35 (6), 823-824, 2019 | 14 | 2019 |
| MYC determines lineage commitment in KRAS-driven primary liver cancer development L D’Artista, AA Moschopoulou, I Barozzi, AJ Craig, M Seehawer, ... Journal of Hepatology 79 (1), 141-149, 2023 | 8 | 2023 |
| Breast cancer prevention by short-term inhibition of TGFβ signaling M Alečković, S Cristea, CR Gil Del Alcazar, P Yan, L Ding, ED Krop, ... Nature communications 13 (1), 7558, 2022 | 7 | 2022 |
| Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer. M Seehawer, F Heinzmann, L D'Artista, J Harbig, PF Roux, L Hoenicke, ... Nature 564 (7735), E9-E9, 2018 | 6 | 2018 |
| GATA3 Silencing Defines a Distinct Subset of ETP-ALL. L Fransecky, M Neumann, S Heesch, M Seehawer, C Schlee, ... Blood 120 (21), 2389, 2012 | 2 | 2012 |
| Heterogeneity and transcriptional drivers of triple-negative breast cancer B Jovanović, D Temko, LE Stevens, M Seehawer, A Fassl, K Murphy, ... Cell reports 42 (12), 2023 | 1 | 2023 |
| Abstract LB-335: Induction of Ribosomal Checkpoint Induced Senescence (RCIS) for the treatment of liver cancer K Wolter, M Pesic, S Klotz, N Herranz, T Wuestefeld, TW Kang, ... Cancer Research 77 (13_Supplement), LB-335-LB-335, 2017 | 1 | 2017 |
| FAT1 Expression and Mutation Status In Adult Acute Lymphoblastic Leukemia M Neumann, M Seehawer, C Schlee, S Vosberg, S Heesch, ... Blood 122 (21), 2564, 2013 | 1 | 2013 |
| Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 M Seehawer, Z Li, J Nishida, P Foidart, AH Reiter, E Rojas-Jimenez, ... Nature Cell Biology, 1-11, 2024 | | 2024 |
| Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies MA Goyette, LE Stevens, CR DePinho, M Seehawer, J Nishida, Z Li, ... Proceedings of the National Academy of Sciences 121 (20), e2322688121, 2024 | | 2024 |
| Development and characterization of kinase sparing TPX2-tethering Aurora kinase A ligands for cancer therapy AA Moschopoulou, M Henning, B Wagner, D Flötgen, J Reiner, ... Cancer Research 84 (6_Supplement), 4478-4478, 2024 | | 2024 |
